Ignite Creation Date:
2025-12-24 @ 3:36 PM
Ignite Modification Date:
2026-01-01 @ 2:14 PM
Study NCT ID:
NCT00450892
Status:
COMPLETED
Last Update Posted:
2016-07-07
First Post:
2007-03-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-07
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-20
First Submit QC Date:
None
Study First Post Date:
2007-03-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-06
Last Update Post Date:
2016-07-07
Last Update Post Date Type:
ESTIMATED